Almac links with MSD in research collaboration by Selina McKee | Apr 30, 2020 | News | 0 Almac and MSD will initially work together in a two-year joint research programme Read More
US Orphan status for Almac’s ovarian cancer drug by Selina McKee | Jul 5, 2017 | News | 0 In big news for Northern Ireland-headquartered drug discovery group Almac, US regulators have awarded orphan drug status to the firm’s experimental drug for ovarian cancer. Read More